<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Gastroenterol Res Pract</journal-id><journal-id journal-id-type="iso-abbrev">Gastroenterol Res Pract</journal-id><journal-id journal-id-type="publisher-id">GRP</journal-id><journal-title-group><journal-title>Gastroenterology Research and Practice</journal-title></journal-title-group><issn pub-type="ppub">1687-6121</issn><issn pub-type="epub">1687-630X</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4925953</article-id><article-id pub-id-type="doi">10.1155/2016/8431480</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Screening Driving Transcription Factors in the Processing of Gastric Cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Guangzhong</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Kai</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Nengwei</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Bin</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Guosheng</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor2">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China</aff><aff id="I2"><sup>2</sup>Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China</aff><author-notes><corresp id="cor1">*Nengwei Zhang: <email>nengwei_zhang@sina.com</email> and </corresp><corresp id="cor2">*Guosheng Feng: <email>guosheng_feng@sina.com</email></corresp><fn fn-type="other"><p>Academic Editor: Niccola Funel</p></fn></author-notes><pub-date pub-type="ppub"><year>2016</year></pub-date><pub-date pub-type="epub"><day>15</day><month>6</month><year>2016</year></pub-date><volume>2016</volume><elocation-id>8431480</elocation-id><history><date date-type="received"><day>22</day><month>12</month><year>2015</year></date><date date-type="rev-recd"><day>18</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>16</day><month>3</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Guangzhong Xu et al.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<italic>Background</italic>. Construction of the transcriptional regulatory network can provide additional clues on the regulatory mechanisms and therapeutic applications in gastric cancer.<italic> Methods</italic>. Gene expression profiles of gastric cancer were downloaded from GEO database for integrated analysis. All of DEGs were analyzed by GO enrichment and KEGG pathway enrichment. Transcription factors were further identified and then a global transcriptional regulatory network was constructed.<italic> Results</italic>. By integrated analysis of the six eligible datasets (340 cases and 43 controls), a bunch of 2327 DEGs were identified, including 2100 upregulated and 227 downregulated DEGs. Functional enrichment analysis of DEGs showed that digestion was a significantly enriched GO term for biological process. Moreover, there were two important enriched KEGG pathways: cell cycle and homologous recombination. Furthermore, a total of 70 differentially expressed TFs were identified and the transcriptional regulatory network was constructed, which consisted of 566 TF-target interactions. The top ten TFs regulating most downstream target genes were BRCA1, ARID3A, EHF, SOX10, ZNF263, FOXL1, FEV, GATA3, FOXC1, and FOXD1. Most of them were involved in the carcinogenesis of gastric cancer.<italic> Conclusion</italic>. The transcriptional regulatory network can help researchers to further clarify the underlying regulatory mechanisms of gastric cancer tumorigenesis. </p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>As one of the most common malignant tumors, gastric cancer is the third cause of cancer-related mortality worldwide, which is mainly related to late presentation. Its incidence is affected by various genetic and environmental factors, reflecting a characteristic geographical distribution. Eastern Asia, Central and Eastern Europe, and South America are higher-risk areas, whereas Northern America and most parts of Africa are low-risk areas [<xref rid="B1" ref-type="bibr">1</xref>]. Therefore, it is urgent to uncover the underling regulatory mechanism of gastric cancer tumorigenesis and identify the useful targets for early diagnosis and treatment.</p><p>Many researchers have devoted themselves to study the pathogenesis of gastric cancer and look for the potential targets for diagnosis and treatment. At present, several factors, such as HER2, VEGF, FEGFR, and mammalian target of rapamycin (mTOR), have been considered as targets of therapy for gastric cancer [<xref rid="B2" ref-type="bibr">2</xref>]. By bioinformatics method, Jian and Chen suggested that two potentially critical transcription factors, E2F1 and STAT1, may play vital roles in progression of gastric cancer [<xref rid="B3" ref-type="bibr">3</xref>]. Recently, the TF-miRNA coregulatory network was constructed, which provided the first evidence to illustrate that altered gene network was associated with gastric cancer invasion [<xref rid="B4" ref-type="bibr">4</xref>].</p><p>To date, there are still no definitive tools for the diagnosis of gastric carcinoma, due to the fact that regulatory mechanism of gastric cancer is not clarified. The integration of multiple microarray studies may be useful to provide additional evidence for understanding the regulatory mechanism. Herein, we conducted integrated analysis of gastric cancer microarray data and identified more candidate differentially expressed genes (DEGs) between gastric cancer and normal control tissues. Moreover, the significantly enriched functions of these genes were screened and analyzed to discover the biological processes and signaling pathways associated with gastric cancer. A transcriptional regulatory network was further constructed.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Microarray Data</title><p>Gene Expression Omnibus (GEO) database is a public functional genomics data repository (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>) [<xref rid="B5" ref-type="bibr">5</xref>]. The following key words were used: (&#x0201c;gastric cancer&#x0201d; [MeSH Terms] OR gastric cancer [All Fields]) AND &#x0201c;Homo sapiens&#x0201d; [porgn] AND &#x0201c;gse&#x0201d; [Filter]. The study type was defined as &#x0201c;expression profiling by array.&#x0201d; All the expression profiles were measured using the platform of Affymetrix Human Genome U133 Plus 2.0 Array. All the cancer and normal adjacent gastric tissues were obtained by resection during surgery and immediately frozen in liquid nitrogen.</p></sec><sec id="sec2.2"><title>2.2. Identifying DEGs by Information Theoretic Analysis</title><p>Firstly, the six datasets were preprocessed by background correction and normalization. Limma package [<xref rid="B6" ref-type="bibr">6</xref>] is the most popular method for the analysis of DEGs, and the gastric cancer and normal samples were compared using Limma package in order to identify the DEGs between the two tissue types. <italic>P</italic> value was determined by R software using the two-tailed Student's <italic>t</italic>-test [<xref rid="B7" ref-type="bibr">7</xref>], and the further false discovery rate (FDR) was further calculated. The gene with FDR &#x0003c; 0.01 was considered to indicate a DEG.</p></sec><sec id="sec2.3"><title>2.3. Functional Annotation of DEGs</title><p>In order to assess the changes in DEGs occurring at the cellular level and the functional clustering of DEGs, the enrichment analysis tool GeneCodis3 (<ext-link ext-link-type="uri" xlink:href="http://genecodis.cnb.csic.es/analysis/">http://genecodis.cnb.csic.es/analysis/</ext-link>) was used to uncover the biological meaning for groups of genes [<xref rid="B8" ref-type="bibr">8</xref>], including Gene Ontology (GO) categories [<xref rid="B9" ref-type="bibr">9</xref>] and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotation [<xref rid="B10" ref-type="bibr">10</xref>].</p></sec><sec id="sec2.4"><title>2.4. Screening the Target Sites of Potential Transcription Factors (TFs)</title><p>DEGs between gastric cancer and normal tissues could be activated or repressed by TFs. All the TFs in human genome and the motifs of genomic binding sites were downloaded from the TRANSFAC database [<xref rid="B11" ref-type="bibr">11</xref>]. Moreover, the position weight matrix (PWM) was also downloaded for gene promoter scanning [<xref rid="B12" ref-type="bibr">12</xref>]. The target sites of potential TFs were then identified. Combined with the DEGs obtained from integrated analysis, the differentially expressed targets were screened. Finally, the transcriptional regulatory network was constructed and visualized by Cytoscape software [<xref rid="B13" ref-type="bibr">13</xref>].</p></sec><sec id="sec2.5"><title>2.5. Online Validation of Differentially Expressed TFs</title><p>The online tool Cancer Browser (<ext-link ext-link-type="uri" xlink:href="https://genome-cancer.ucsc.edu/proj/site/hgHeatmap/">https://genome-cancer.ucsc.edu/proj/site/hgHeatmap/</ext-link>) was used to verify the expression of top ten differentially expressed TFs, which regulated the most downstream target genes. We selected the dataset of TCGA stomach adenocarcinoma (STAD) gene expression by RNAseq (Illumina HiSeq), in which 421 samples were enrolled, including 384 cases and 37 normal controls. The dataset ID was TCGA_STAD_exp_HiSeq. We input the names of top ten TFs in the &#x0201c;Genes&#x0201d; item on the top of screen and then clicked the &#x0201c;Go&#x0201d; button and the heat map would appear automatically, which represented the expression level for TFs in different samples.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Identification of DEGs in Gastric Cancer</title><p>According to the inclusion criteria, we downloaded six gene expression profiles of gastric cancer from microarray experiments. GEO IDs were GSE13911, GSE19826, GSE34942, GSE35809, GSE51105, and GSE57303. Totally, there were 340 tumor samples and 43 normal gastric tissues, respectively. The types of samples were as follows: GSE13911 (26 intestinal + 6 diffuse + 4 mixed + 2 unclassified), GSE19826 (unknown Lauren subtype), GSE34942 (39 intestinal + 11 diffuse + 6 unclassified), GSE35809 (34 intestinal + 30 diffuse + 6 unclassified), GSE51105 (49 intestinal + 35 diffuse + 10 mixed), and GSE57303 (Lauren subtype not further provided). The characteristics of eligible datasets were summarized in <xref ref-type="table" rid="tab1">Table 1</xref>.</p><p>Integrated analysis of six microarray datasets led to 17481 genes. Using the FDR &#x0003c; 0.01 as the statistical significance threshold, a total of 2327 DEGs were identified, including 2100 upregulated DEGs and 227 downregulated DEGs. The top ten upregulated and downregulated DEGs between gastric cancer and normal tissues were listed in <xref ref-type="table" rid="tab2">Table 2</xref>.</p></sec><sec id="sec3.2"><title>3.2. Functional Enrichment Analysis of DEGs</title><p>GO enrichment analysis of DEGs was performed to understand their biological functions. In our present study, the three GO categories (biological process, cellular component, and molecular function) were detected, respectively, using web-based software GeneCodis3. The results of enrichment analysis showed that the significantly enriched GO terms for biological process were multicellular organismal process (GO: 32501, FDR = 1.85<italic>E</italic> &#x02212; 09) and digestion (GO: 7586, FDR = 6.11<italic>E</italic> &#x02212; 09) (<xref ref-type="table" rid="tab3">Table 3</xref>). Moreover, the extracellular space (GO: 5615, FDR = 4.55<italic>E</italic> &#x02212; 10) was the significantly enriched GO term for cellular component. Notably, the significantly enriched GO term for molecular functions was extracellular matrix structural constituent (GO: 0005201, FDR = 2.82<italic>E</italic> &#x02212; 04).</p><p>Moreover, the KEGG pathway enrichment analysis indicated that cell cycle (FDR = 4.81<italic>E</italic> &#x02212; 33) was significantly enriched (<xref ref-type="table" rid="tab4">Table 4</xref>). Furthermore, several pathways were also significantly enriched which may be closely related to transcription and translation process, including spliceosome (FDR = 5.45<italic>E</italic> &#x02212; 34), RNA transport (FDR = 8.58<italic>E</italic> &#x02212; 23), ribosome biogenesis in eukaryotes (FDR = 5.29<italic>E</italic> &#x02212; 22), and homologous recombination (FDR = 3.89<italic>E</italic> &#x02212; 08).</p></sec><sec id="sec3.3"><title>3.3. Building Up TFs-Target Genes Regulatory Network for Gastric Cancer</title><p>In order to display the TFs-target genes regulatory network for gastric cancer, we utilized TRANSFAC to inquire TFs and their latent target genes and then selected the differentially expressed TFs and latent target genes in gastric cancer tissues. We found a total of 70 differentially expressed TFs (54 upregulated and 16 downregulated) and 470 latent differentially expressed target genes in gastric cancer, respectively (<xref ref-type="table" rid="tab5">Table 5</xref>). And, based on them, the transcriptional regulatory network was subsequently constructed. In the network, there were 63 TFs (49 upregulated and 14 downregulated) and 566 TF-target interactions in the context of gastric cancer (<xref ref-type="fig" rid="fig1">Figure 1</xref>). No differentially expressed target genes were found for the other seven TFs. In the network, the top ten TFs regulating most downstream target genes were BRCA1, ARID3A, EHF, SOX10, ZNF263, FOXL1, FEV, GATA3, FOXC1, and FOXD1. The three hub TFs were BRCA1 (degree = 49), ARID3A (degree = 47), and EHF (degree = 42).</p></sec><sec id="sec3.4"><title>3.4. Online Validation of Differentially Expressed TFs</title><p>The top ten differentially expressed TFs were selected for validation. The online validation revealed that expression patterns of the top ten TFs were similar to the integrated analysis. The results revealed that SOX10 and FEV were downregulated, while BRCA1, ARID3A, EHF, ZNF263, FOXL1, GATA3, FOXC1, and FOXD1 were upregulated in primary gastric adenocarcinoma compared with the normal lung tissue (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>Gastric cancer has few symptoms during the early stages, and most patients are usually diagnosed after the cancer has progressed to an advanced stage, which results in short survival times. Therefore, the high mortality rate underlines the need for early diagnosis and effective medical treatments for the patients [<xref rid="B14" ref-type="bibr">14</xref>]. The transcriptional regulatory network may be helpful to understand the underlying regulatory mechanisms and provide additional evidence for therapeutic applications.</p><p>In this study, according to integrated analysis of six microarray datasets for gastric cancer, 2327 DEGs were identified (2100 upregulated and 227 downregulated). We also observed that digestion (GO: 7586, FDR = 6.11<italic>E</italic> &#x02212; 09) was a significantly enriched GO term for biological process. The pathway of homologous recombination was also significantly enriched, which is in accordance with the previous study where homologous recombination deficiency directly compromises the genomic stability and predisposes to cancer formation [<xref rid="B15" ref-type="bibr">15</xref>]. Gastric cancer is a multistep and multifactorial process, in which the dynamic balance between the cell proliferation and apoptosis of gastric mucosa was broken. Tumor suppressor gene p53 can be repressed, excessively leading to the gastric epithelial cell proliferation and the apoptosis signal cannot be started. We found that DEGs were significantly enriched in p53 signaling pathway, and various pathways related to cell proliferation were also enriched, such as cell cycle, DNA replication, pyrimidine metabolism, purine metabolism, and mismatch repair. Our results suggested that the above pathways may drive the tumorigenesis of gastric cancer.</p><p>Moreover, 70 differentially expressed TFs were identified and a transcriptional regulatory network was constructed. In the network, top ten TFs regulating most downstream target genes were BRCA1, ARID3A, EHF, SOX10, ZNF263, FOXL1, FEV, GATA3, FOXC1, and FOXD1. Most of them were involved in the progression of gastric cancer.</p><p>BRCA1 is an important tumor suppressor, which plays an essential role in maintaining genomic stability and integrity. BRCA1 was previously suggested as a good prognostic factor for gastric cancer [<xref rid="B16" ref-type="bibr">16</xref>]. It was reported that downregulation of BRCA1 nuclear expression was associated with advanced stage and perineural invasion in sporadic gastric cancer [<xref rid="B17" ref-type="bibr">17</xref>]. The loss of BRCA1 expression may serve as a predictive factor for the progression of gastric cancer [<xref rid="B18" ref-type="bibr">18</xref>].</p><p>ARID3A is a member of the ARID family of DNA-binding proteins. The expression of ARID3A was markedly increased in colon cancer tissue compared with matched normal colonic mucosa. A previous study suggested that strong expression of ARID3A may predict a good prognosis in patients with colorectal carcinoma, and Song et al. mentioned that whether ARID3A acts as an oncogene or tumor suppressor remains controversial [<xref rid="B19" ref-type="bibr">19</xref>]. In our study, we found that ARID3A was upregulated in gastric cancer compared with normal tissues. Therefore, we speculated that ARID3A may act as an oncogene in the development of gastric cancer.</p><p>Abnormalities of SOX factors have been shown to play critical roles in cancer formation and development. SOX10 was identified as a methylated gene in digestive cancers [<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>]. It was also reported that SOX10 exhibits tumor suppressor activity by inducing tumor cell apoptosis, inhibiting invasion, and regulating cell epithelial to mesenchymal transition (EMT) in digestive cancers through suppressing Wnt/<italic>&#x003b2;</italic>-catenin signaling pathway [<xref rid="B22" ref-type="bibr">22</xref>]. Consistent with that, our results also indicated that SOX10 was significantly downregulated in gastric cancer, implying that the reduction of SOX10 expression could be a good predictor for gastric cancer.</p><p>The expression of FOXC1 has significance in the development, progression, and metastasis of gastric cancer, and overexpression of FOXC1 may serve as a useful marker for predicting the outcome of patients with gastric cancer [<xref rid="B23" ref-type="bibr">23</xref>]. Moreover, by comparative transcriptome analysis, Feng et al. found that FOXD1 was an important differentially expressed TF between metastatic gastric cancer and nonmetastatic gastric cancer [<xref rid="B24" ref-type="bibr">24</xref>]. Our results showed that FOXC1 and FOXD1 were upregulated in gastric cancer compared with normal tissues, which provides additional evidence for their roles of potential biomarkers.</p><p>It was reported that FOXL1 was also upregulated in pancreatic intraepithelial neoplasia [<xref rid="B25" ref-type="bibr">25</xref>]. Integration analysis of SNPs and gene expression profile revealed that FOXL1 regulated the most important DEGs of IRX1, SOX1, and MSX1 with risk associated SNP loci, which may serve as candidate biomarkers for diagnosis and prognosis of gastric cancer [<xref rid="B26" ref-type="bibr">26</xref>]. By the FOX family member such as FOXL1, hedgehog signals can induce WNT5A upregulation, which is a cancer-associated gene involved in invasion and metastasis of gastric cancer [<xref rid="B27" ref-type="bibr">27</xref>]. Another study reported that FOXL1 was the first mesenchymal Modifier of Min and plays a key role in gastrointestinal tumorigenesis [<xref rid="B28" ref-type="bibr">28</xref>]. We found that FOXL1 was upregulated in gastric cancer compared with normal tissues, indicating that FOXL1 will be a powerful driver in the progression of gastric cancer.</p><p>The expression level of GATA3 was significantly increased in patients with gastric cancer [<xref rid="B29" ref-type="bibr">29</xref>]. Another study reported that GATA3 plays an important role in tumor progression of gastric adenocarcinoma, and the downregulation of GATA3 is associated with unfavorable prognosis in primary gastric adenocarcinoma [<xref rid="B30" ref-type="bibr">30</xref>]. Specifically, Keshari et al. found that the low GATA3 expression was associated with tumors with deeper invasion, higher lymph node metastatic status, cases with distant metastases, and a later TNM stage [<xref rid="B30" ref-type="bibr">30</xref>]. In our study, GATA3 was upregulated in gastric cancer compared with the normal tissues, which may be partly related to the TNM stage of patients with gastric cancer. Our results suggested that GATA3 plays vital roles in different developmental stages of gastric cancer. Further functional experiments are necessary to better understand the function of GATA3 in gastric cancer.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>Taken together, our integrated analysis discovered a bunch of DEGs in gastric cancer. Moreover, the results of function enrichment analysis revealed that some biological functions or pathways may be closely related to the development of gastric cancer, including digestion, cell cycle, and homologous recombination. The constructed transcriptional regulatory network may be helpful to further understand the underlying regulatory mechanism of gastric cancer. Ten TFs regulating most downstream target genes were obtained: BRCA1, ARID3A, EHF, SOX10, ZNF263, FOXL1, FEV, GATA3, FOXC1, and FOXD1.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>DEGs:</term><def><p>Differentially expressed genes</p></def></def-item><def-item><term>GEO:</term><def><p>Gene Expression Omnibus</p></def></def-item><def-item><term>GO:</term><def><p>Gene Ontology</p></def></def-item><def-item><term>KEGG:</term><def><p>Kyoto Encyclopedia of Genes and Genomes</p></def></def-item><def-item><term>TFs:</term><def><p>Transcription factors.</p></def></def-item></def-list></glossary><sec><title>Competing Interests</title><p>The authors declare that they have no competing interests.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torre</surname><given-names>L. A.</given-names></name><name><surname>Bray</surname><given-names>F.</given-names></name><name><surname>Siegel</surname><given-names>R. L.</given-names></name><name><surname>Ferlay</surname><given-names>J.</given-names></name><name><surname>Lortet-Tieulent</surname><given-names>J.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group><article-title>Global cancer statistics, 2012</article-title><source><italic>CA Cancer Journal for Clinicians</italic></source><year>2015</year><volume>65</volume><issue>2</issue><fpage>87</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.3322/caac.21262</pub-id><pub-id pub-id-type="other">2-s2.0-84924271853</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoyagi</surname><given-names>K.</given-names></name><name><surname>Kouhuji</surname><given-names>K.</given-names></name><name><surname>Kizaki</surname><given-names>J.</given-names></name><name><surname>Isobe</surname><given-names>T.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Shirouzu</surname><given-names>K.</given-names></name></person-group><article-title>Molecular targeting to treat gastric cancer</article-title><source><italic>World Journal of Gastroenterology</italic></source><year>2014</year><volume>20</volume><issue>38</issue><fpage>13741</fpage><lpage>13755</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i38.13741</pub-id><pub-id pub-id-type="other">2-s2.0-84909989459</pub-id><pub-id pub-id-type="pmid">25320512</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jian</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>Regulatory mechanisms of transcription factors and target genes on gastric cancer by bioinformatics method</article-title><source><italic>Hepato-Gastroenterology</italic></source><year>2015</year><volume>62</volume><issue>138</issue><fpage>524</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.5754/hge1438</pub-id><pub-id pub-id-type="other">2-s2.0-84928561132</pub-id><pub-id pub-id-type="pmid">25916094</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xin</surname><given-names>Z.</given-names></name><name><surname>Duan</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Transcription factors and microRNA-Co-regulated genes in gastric cancer invasion in ex vivo</article-title><source><italic>PLoS ONE</italic></source><year>2015</year><volume>10</volume><issue>4</issue><pub-id pub-id-type="publisher-id">e0122882</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0122882</pub-id><pub-id pub-id-type="other">2-s2.0-84928914579</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>T.</given-names></name><name><surname>Wilhite</surname><given-names>S. E.</given-names></name><name><surname>Ledoux</surname><given-names>P.</given-names></name><etal/></person-group><article-title>NCBI GEO: archive for functional genomics data sets&#x02014;update</article-title><source><italic>Nucleic Acids Research</italic></source><year>2013</year><volume>41</volume><issue>1</issue><fpage>D991</fpage><lpage>D995</lpage><pub-id pub-id-type="doi">10.1093/nar/gks1193</pub-id><pub-id pub-id-type="other">2-s2.0-84874271270</pub-id><pub-id pub-id-type="pmid">23193258</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gentleman</surname><given-names>R.</given-names></name><name><surname>Carey</surname><given-names>V.</given-names></name><name><surname>Huber</surname><given-names>W.</given-names></name><etal/></person-group><source><italic>Bioinformatics and Computational Biology Solutions Using R and Bioconductor</italic></source><year>2006</year><publisher-name>Springer Science &#x00026; Business Media</publisher-name></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>G. K.</given-names></name></person-group><article-title>Linear models and empirical Bayes methods for assessing differential expression in microarray experiments</article-title><source><italic>Statistical Applications in Genetics and Molecular Biology</italic></source><year>2004</year><volume>3, article 3</volume><pub-id pub-id-type="doi">10.2202/1544-6115.1027</pub-id><pub-id pub-id-type="other">MR2101454</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabas-Madrid</surname><given-names>D.</given-names></name><name><surname>Nogales-Cadenas</surname><given-names>R.</given-names></name><name><surname>Pascual-Montano</surname><given-names>A.</given-names></name></person-group><article-title>GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics</article-title><source><italic>Nucleic Acids Research</italic></source><year>2012</year><volume>40</volume><issue>1</issue><fpage>W478</fpage><lpage>W483</lpage><pub-id pub-id-type="doi">10.1093/nar/gks402</pub-id><pub-id pub-id-type="other">2-s2.0-84864494098</pub-id><pub-id pub-id-type="pmid">22573175</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>M. D.</given-names></name><name><surname>Wakefield</surname><given-names>M. J.</given-names></name><name><surname>Smyth</surname><given-names>G. K.</given-names></name><name><surname>Oshlack</surname><given-names>A.</given-names></name></person-group><article-title>Gene ontology analysis for RNA-seq: accounting for selection bias</article-title><source><italic>Genome Biology</italic></source><year>2010</year><volume>11</volume><issue>2, article R14</issue><pub-id pub-id-type="doi">10.1186/gb-2010-11-2-r14</pub-id><pub-id pub-id-type="other">2-s2.0-77953212372</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M.</given-names></name><name><surname>Goto</surname><given-names>S.</given-names></name></person-group><article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title><source><italic>Nucleic Acids Research</italic></source><year>2000</year><volume>28</volume><issue>1</issue><fpage>27</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id><pub-id pub-id-type="other">2-s2.0-0033982936</pub-id><pub-id pub-id-type="pmid">10592173</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingender</surname><given-names>E.</given-names></name></person-group><article-title>The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation</article-title><source><italic>Briefings in Bioinformatics</italic></source><year>2008</year><volume>9</volume><issue>4</issue><fpage>326</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1093/bib/bbn016</pub-id><pub-id pub-id-type="other">2-s2.0-46049087782</pub-id><pub-id pub-id-type="pmid">18436575</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kn&#x000fc;ppel</surname><given-names>R.</given-names></name><name><surname>Dietze</surname><given-names>P.</given-names></name><name><surname>Lehnberg</surname><given-names>W.</given-names></name><name><surname>Frech</surname><given-names>K.</given-names></name><name><surname>Wingender</surname><given-names>E.</given-names></name></person-group><article-title>TRANSFAC retrieval program: a network model database of eukaryotic transcription regulating sequences and proteins</article-title><source><italic>Journal of Computational Biology</italic></source><year>1994</year><volume>1</volume><issue>3</issue><fpage>191</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1089/cmb.1994.1.191</pub-id><pub-id pub-id-type="other">2-s2.0-0028505429</pub-id><pub-id pub-id-type="pmid">8790464</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smoot</surname><given-names>M. E.</given-names></name><name><surname>Ono</surname><given-names>K.</given-names></name><name><surname>Ruscheinski</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>P.-L.</given-names></name><name><surname>Ideker</surname><given-names>T.</given-names></name></person-group><article-title>Cytoscape 2.8: new features for data integration and network visualization</article-title><source><italic>Bioinformatics</italic></source><year>2011</year><volume>27</volume><issue>3</issue><fpage>431</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq675</pub-id><pub-id pub-id-type="other">2-s2.0-79551587720</pub-id><pub-id pub-id-type="pmid">21149340</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>K.</given-names></name><name><surname>Sakuramoto</surname><given-names>S.</given-names></name><name><surname>Nemoto</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Trend in gastric cancer: 35 years of surgical experience in Japan</article-title><source><italic>World Journal of Gastroenterology</italic></source><year>2011</year><volume>17</volume><issue>29</issue><fpage>3390</fpage><lpage>3397</lpage><pub-id pub-id-type="doi">10.3748/wjg.v17.i29.3390</pub-id><pub-id pub-id-type="other">2-s2.0-80051970208</pub-id><pub-id pub-id-type="pmid">21876631</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeijmakers</surname><given-names>J. H. J.</given-names></name></person-group><article-title>DNA damage, aging, and cancer</article-title><source><italic>New England Journal of Medicine</italic></source><year>2009</year><volume>361</volume><issue>15</issue><fpage>1475</fpage><lpage>1485</lpage><pub-id pub-id-type="doi">10.1056/NEJMra0804615</pub-id><pub-id pub-id-type="other">2-s2.0-70349859881</pub-id><pub-id pub-id-type="pmid">19812404</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Prognostic significance of BRCA1 expression in gastric cancer</article-title><source><italic>Medical Oncology</italic></source><year>2013</year><volume>30</volume><issue>1, article 423</issue><pub-id pub-id-type="doi">10.1007/s12032-012-0423-5</pub-id><pub-id pub-id-type="other">2-s2.0-84880615002</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. W.</given-names></name><name><surname>Cho</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer</article-title><source><italic>Cancer Chemotherapy and Pharmacology</italic></source><year>2013</year><volume>71</volume><issue>6</issue><fpage>1435</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1007/s00280-013-2141-x</pub-id><pub-id pub-id-type="other">2-s2.0-84878666473</pub-id><pub-id pub-id-type="pmid">23633032</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.-Z.</given-names></name><name><surname>Liu</surname><given-names>Y. J. C.</given-names></name><name><surname>Yin</surname><given-names>X.-L.</given-names></name><name><surname>Zhan</surname><given-names>P.</given-names></name><name><surname>Gu</surname><given-names>Y.</given-names></name><name><surname>Ni</surname><given-names>X.-Z.</given-names></name></person-group><article-title>Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma</article-title><source><italic>World Journal of Gastroenterology</italic></source><year>2013</year><volume>19</volume><issue>12</issue><fpage>1968</fpage><lpage>1974</lpage><pub-id pub-id-type="doi">10.3748/wjg.v19.i12.1968</pub-id><pub-id pub-id-type="other">2-s2.0-84875594162</pub-id><pub-id pub-id-type="pmid">23569343</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>W. K. Y.</given-names></name><name><surname>Hong</surname><given-names>S. P. I.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name></person-group><article-title>High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma</article-title><source><italic>Annals of Surgical Oncology</italic></source><year>2014</year><volume>21</volume><issue>supplement 4</issue><fpage>S481</fpage><lpage>S489</lpage><pub-id pub-id-type="doi">10.1245/s10434-013-3435-2</pub-id><pub-id pub-id-type="other">2-s2.0-84942615567</pub-id><pub-id pub-id-type="pmid">24366420</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Double restriction-enzyme digestion improves the coverage and accuracy of genome-wide CpG methylation profiling by reduced representation bisulfite sequencing</article-title><source><italic>BMC Genomics</italic></source><year>2013</year><volume>14, article 11</volume><pub-id pub-id-type="doi">10.1186/1471-2164-14-11</pub-id><pub-id pub-id-type="other">2-s2.0-84872175934</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><etal/></person-group><article-title>WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/<italic>&#x003b2;</italic>-catenin signaling, and is frequently methylated in colorectal cancer</article-title><source><italic>Clinical Cancer Research</italic></source><year>2008</year><volume>14</volume><issue>1</issue><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.ccr-07-1644</pub-id><pub-id pub-id-type="other">2-s2.0-40749119357</pub-id><pub-id pub-id-type="pmid">18172252</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><etal/></person-group><article-title>SOX10, a novel HMG-box-containing tumor suppressor, inhibits growth and metastasis of digestive cancers by suppressing the wnt/<italic>&#x003b2;</italic>-catenin pathway</article-title><source><italic>Oncotarget</italic></source><year>2014</year><volume>5</volume><issue>21</issue><fpage>10571</fpage><lpage>10583</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.2512</pub-id><pub-id pub-id-type="other">2-s2.0-84916919338</pub-id><pub-id pub-id-type="pmid">25301735</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Shao</surname><given-names>Q.-S.</given-names></name><name><surname>Yao</surname><given-names>H.-B.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Y.-Y.</given-names></name><name><surname>Jia</surname><given-names>L.-H.</given-names></name></person-group><article-title>Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients</article-title><source><italic>Histopathology</italic></source><year>2014</year><volume>64</volume><issue>7</issue><fpage>963</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1111/his.12347</pub-id><pub-id pub-id-type="other">2-s2.0-84899960463</pub-id><pub-id pub-id-type="pmid">24329718</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>D.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Wei</surname><given-names>Z.</given-names></name><name><surname>Cai</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Comparative transcriptome analysis between metastatic and non-metastatic gastric cancer reveals potential biomarkers</article-title><source><italic>Molecular medicine reports</italic></source><year>2015</year><volume>11</volume><issue>1</issue><fpage>386</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.3892/mmr.2014.2709</pub-id><pub-id pub-id-type="other">2-s2.0-84936069486</pub-id><pub-id pub-id-type="pmid">25334039</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>N. B.</given-names></name><name><surname>Biankin</surname><given-names>A. V.</given-names></name><name><surname>Fukushima</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells</article-title><source><italic>Cancer Research</italic></source><year>2005</year><volume>65</volume><issue>5</issue><fpage>1619</fpage><lpage>1626</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.can-04-1413</pub-id><pub-id pub-id-type="other">2-s2.0-16444378654</pub-id><pub-id pub-id-type="pmid">15753353</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>P.</given-names></name></person-group><article-title>Identifying novel biomarkers of gastric cancer through integration analysis of single nucleotide polymorphisms and gene expression profile</article-title><source><italic>International Journal of Biological Markers</italic></source><year>2015</year><volume>30</volume><issue>3</issue><fpage>e321</fpage><lpage>e326</lpage><pub-id pub-id-type="doi">10.5301/jbm.5000145</pub-id><pub-id pub-id-type="other">2-s2.0-84937872225</pub-id><pub-id pub-id-type="pmid">25982683</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname><given-names>M.</given-names></name><name><surname>Katoh</surname><given-names>M.</given-names></name></person-group><article-title>Transcriptional mechanisms of WNT5A based on NF-<italic>&#x003ba;</italic>B, Hedgehog, TGF<italic>&#x003b2;</italic>, and Notch signaling cascades</article-title><source><italic>International Journal of Molecular Medicine</italic></source><year>2009</year><volume>23</volume><issue>6</issue><fpage>763</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.3892/ijmm_00000190</pub-id><pub-id pub-id-type="other">2-s2.0-67649515610</pub-id><pub-id pub-id-type="pmid">19424602</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perreault</surname><given-names>N.</given-names></name><name><surname>Sackett</surname><given-names>S. D.</given-names></name><name><surname>Katz</surname><given-names>J. P.</given-names></name><name><surname>Furth</surname><given-names>E. E.</given-names></name><name><surname>Kaestner</surname><given-names>K. H.</given-names></name></person-group><article-title>Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon</article-title><source><italic>Genes and Development</italic></source><year>2005</year><volume>19</volume><issue>3</issue><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1101/gad.1260605</pub-id><pub-id pub-id-type="other">2-s2.0-13244273712</pub-id><pub-id pub-id-type="pmid">15650110</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bie</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Su</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer</article-title><source><italic>Journal of Immunology Research</italic></source><year>2014</year><volume>2014</volume><fpage>10</fpage><pub-id pub-id-type="publisher-id">923135</pub-id><pub-id pub-id-type="doi">10.1155/2014/923135</pub-id><pub-id pub-id-type="other">2-s2.0-84897015493</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keshari</surname><given-names>R. P.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma</article-title><source><italic>PLoS ONE</italic></source><year>2014</year><volume>9</volume><issue>2</issue><pub-id pub-id-type="publisher-id">e87195</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0087195</pub-id><pub-id pub-id-type="other">2-s2.0-84895109905</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Errico</surname><given-names>M.</given-names></name><name><surname>de Rinaldis</surname><given-names>E.</given-names></name><name><surname>Blasi</surname><given-names>M. F.</given-names></name><etal/></person-group><article-title>Genome-wide expression profile of sporadic gastric cancers with microsatellite instability</article-title><source><italic>European Journal of Cancer</italic></source><year>2009</year><volume>45</volume><issue>3</issue><fpage>461</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2008.10.032</pub-id><pub-id pub-id-type="other">2-s2.0-59149095034</pub-id><pub-id pub-id-type="pmid">19081245</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Wen</surname><given-names>Y. G.</given-names></name><name><surname>Li</surname><given-names>D. P.</given-names></name><etal/></person-group><article-title>Upregulated INHBA expression is associated with poor survival in gastric cancer</article-title><source><italic>Medical Oncology</italic></source><year>2012</year><volume>29</volume><issue>1</issue><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1007/s12032-010-9766-y</pub-id><pub-id pub-id-type="pmid">21132402</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>Z.</given-names></name><name><surname>Tan</surname><given-names>I. B.</given-names></name><name><surname>Das</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil</article-title><source><italic>Gastroenterology</italic></source><year>2013</year><volume>145</volume><issue>3</issue><fpage>554</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.05.010</pub-id><pub-id pub-id-type="other">2-s2.0-84883185766</pub-id><pub-id pub-id-type="pmid">23684942</pub-id></element-citation></ref><ref id="B35"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busuttil</surname><given-names>R. A.</given-names></name><name><surname>George</surname><given-names>J.</given-names></name><name><surname>Tothill</surname><given-names>R. W.</given-names></name><etal/></person-group><article-title>A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response</article-title><source><italic>Clinical Cancer Research</italic></source><year>2014</year><volume>20</volume><issue>10</issue><fpage>2761</fpage><lpage>2772</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.ccr-13-3049</pub-id><pub-id pub-id-type="other">2-s2.0-84901064254</pub-id><pub-id pub-id-type="pmid">24658156</pub-id></element-citation></ref><ref id="B36"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Z.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Tang</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Whole genome gene copy number profiling of gastric cancer identifies <italic>PAK1</italic> and <italic>KRAS</italic> gene amplification as therapy targets</article-title><source><italic>Genes Chromosomes and Cancer</italic></source><year>2014</year><volume>53</volume><issue>11</issue><fpage>883</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1002/gcc.22196</pub-id><pub-id pub-id-type="other">2-s2.0-84927570856</pub-id><pub-id pub-id-type="pmid">24935174</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The established transcriptional regulatory network in gastric cancer. Rectangle indicates TFs, and ellipse indicates target genes. Red-color and green-color nodes represent products of upregulated and downregulated TFs, respectively. Blue nodes indicate differentially expressed target genes.</p></caption><graphic xlink:href="GRP2016-8431480.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Heat map of top ten differentially expressed TFs in the dataset of TCGA stomach adenocarcinoma (STAD) gene expression by RNAseq. Sample type: green indicates the primary tumor of stomach adenocarcinoma (<italic>n</italic> = 384); grey indicates the normal lung tissue (<italic>n</italic> = 37). For each gene, red is upregulated and blue is downregulated in the corresponding sample.</p></caption><graphic xlink:href="GRP2016-8431480.002"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristics of the six microarray datasets for integrated analysis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">GEO ID</th><th align="center" rowspan="1" colspan="1">Platform</th><th align="center" rowspan="1" colspan="1">Sample (case&#x02009;:&#x02009;control)</th><th align="center" rowspan="1" colspan="1">Country</th><th align="center" rowspan="1" colspan="1">Year</th><th align="center" rowspan="1" colspan="1">Author</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GSE13911</td><td align="center" rowspan="1" colspan="1">GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array</td><td align="center" rowspan="1" colspan="1">38&#x02009;:&#x02009;31</td><td align="center" rowspan="1" colspan="1">Itay</td><td align="center" rowspan="1" colspan="1">2008</td><td align="center" rowspan="1" colspan="1">D'Errico et al. [<xref rid="B31" ref-type="bibr">31</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">GSE19826</td><td align="center" rowspan="1" colspan="1">GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array</td><td align="center" rowspan="1" colspan="1">12&#x02009;:&#x02009;12</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">Wang et al. [<xref rid="B32" ref-type="bibr">32</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">GSE34942</td><td align="center" rowspan="1" colspan="1">GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array</td><td align="center" rowspan="1" colspan="1">56&#x02009;:&#x02009;0</td><td align="center" rowspan="1" colspan="1">Singapore</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">Lei et al. [<xref rid="B33" ref-type="bibr">33</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">GSE35809</td><td align="center" rowspan="1" colspan="1">GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array</td><td align="center" rowspan="1" colspan="1">70&#x02009;:&#x02009;0</td><td align="center" rowspan="1" colspan="1">Singapore</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">Lei et al. [<xref rid="B33" ref-type="bibr">33</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">GSE51105</td><td align="center" rowspan="1" colspan="1">GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array</td><td align="center" rowspan="1" colspan="1">94&#x02009;:&#x02009;0</td><td align="center" rowspan="1" colspan="1">Australia</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">Busuttil et al. [<xref rid="B35" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">GSE57303</td><td align="center" rowspan="1" colspan="1">GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array</td><td align="center" rowspan="1" colspan="1">70&#x02009;:&#x02009;0</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">Qian et al. [<xref rid="B36" ref-type="bibr">35</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Top ten upregulated and downregulated DEGs between gastric cancer and normal tissues.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Symbol</th><th align="center" rowspan="1" colspan="1">Log FC</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CST1</td><td align="center" rowspan="1" colspan="1">5.02<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">3.12<italic>E</italic> &#x02212; 29</td></tr><tr><td align="left" rowspan="1" colspan="1">MMP11</td><td align="center" rowspan="1" colspan="1">3.27<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">5.35<italic>E</italic> &#x02212; 24</td></tr><tr><td align="left" rowspan="1" colspan="1">COL1A1</td><td align="center" rowspan="1" colspan="1">3.27<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">1.21<italic>E</italic> &#x02212; 30</td></tr><tr><td align="left" rowspan="1" colspan="1">GDF15</td><td align="center" rowspan="1" colspan="1">3.10<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">5.16<italic>E</italic> &#x02212; 29</td></tr><tr><td align="left" rowspan="1" colspan="1">UBD</td><td align="center" rowspan="1" colspan="1">3.02<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">8.33<italic>E</italic> &#x02212; 18</td></tr><tr><td align="left" rowspan="1" colspan="1">APOC1</td><td align="center" rowspan="1" colspan="1">3.02<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">1.03<italic>E</italic> &#x02212; 25</td></tr><tr><td align="left" rowspan="1" colspan="1">SPP1</td><td align="center" rowspan="1" colspan="1">2.92<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">1.67<italic>E</italic> &#x02212; 16</td></tr><tr><td align="left" rowspan="1" colspan="1">CTHRC1</td><td align="center" rowspan="1" colspan="1">2.85<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">3.95<italic>E</italic> &#x02212; 30</td></tr><tr><td align="left" rowspan="1" colspan="1">COL10A1</td><td align="center" rowspan="1" colspan="1">2.84<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">1.95<italic>E</italic> &#x02212; 19</td></tr><tr><td align="left" rowspan="1" colspan="1">INHBA</td><td align="center" rowspan="1" colspan="1">2.80<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">8.79<italic>E</italic> &#x02212; 33</td></tr><tr><td align="left" rowspan="1" colspan="1">GKN1</td><td align="center" rowspan="1" colspan="1">&#x02212;5.70<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">6.73<italic>E</italic> &#x02212; 17</td></tr><tr><td align="left" rowspan="1" colspan="1">GKN2</td><td align="center" rowspan="1" colspan="1">&#x02212;4.57<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">7.42<italic>E</italic> &#x02212; 19</td></tr><tr><td align="left" rowspan="1" colspan="1">PGA3</td><td align="center" rowspan="1" colspan="1">&#x02212;4.45<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">2.89<italic>E</italic> &#x02212; 16</td></tr><tr><td align="left" rowspan="1" colspan="1">MAL</td><td align="center" rowspan="1" colspan="1">&#x02212;4.19<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">1.50<italic>E</italic> &#x02212; 33</td></tr><tr><td align="left" rowspan="1" colspan="1">PGA5 </td><td align="center" rowspan="1" colspan="1">&#x02212;3.73<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">1.24<italic>E</italic> &#x02212; 19</td></tr><tr><td align="left" rowspan="1" colspan="1">ATP4B</td><td align="center" rowspan="1" colspan="1">&#x02212;3.49<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">7.36<italic>E</italic> &#x02212; 24</td></tr><tr><td align="left" rowspan="1" colspan="1">GIF</td><td align="center" rowspan="1" colspan="1">&#x02212;3.33<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">4.22<italic>E</italic> &#x02212; 17</td></tr><tr><td align="left" rowspan="1" colspan="1">ATP4A</td><td align="center" rowspan="1" colspan="1">&#x02212;3.24<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">2.52<italic>E</italic> &#x02212; 24</td></tr><tr><td align="left" rowspan="1" colspan="1">DPT</td><td align="center" rowspan="1" colspan="1">&#x02212;3.22<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">1.67<italic>E</italic> &#x02212; 32</td></tr><tr><td align="left" rowspan="1" colspan="1">C2orf40</td><td align="center" rowspan="1" colspan="1">&#x02212;3.17<italic>E</italic> + 00</td><td align="center" rowspan="1" colspan="1">5.14<italic>E</italic> &#x02212; 17</td></tr></tbody></table></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Enriched GO terms of DEGs between gastric cancer and normal tissues.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">GO ID</th><th align="center" rowspan="1" colspan="1">GO term</th><th align="center" rowspan="1" colspan="1">Number of genes</th><th align="center" rowspan="1" colspan="1">FDR</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Biological process</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;32501</td><td align="center" rowspan="1" colspan="1">Multicellular organismal process</td><td align="center" rowspan="1" colspan="1">58</td><td align="center" rowspan="1" colspan="1">1.85<italic>E</italic> &#x02212; 09</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;3008</td><td align="center" rowspan="1" colspan="1">System process</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">1.96<italic>E</italic> &#x02212; 09</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;7586</td><td align="center" rowspan="1" colspan="1">Digestion</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">6.11<italic>E</italic> &#x02212; 09</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;44707</td><td align="center" rowspan="1" colspan="1">Single-multicellular organismal process</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">6.97<italic>E</italic> &#x02212; 09</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;42391</td><td align="center" rowspan="1" colspan="1">Regulation of membrane potential</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">1.14<italic>E</italic> &#x02212; 06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;44057</td><td align="center" rowspan="1" colspan="1">Regulation of system process</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">1.23<italic>E</italic> &#x02212; 06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;7610</td><td align="center" rowspan="1" colspan="1">Behavior</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">1.27<italic>E</italic> &#x02212; 06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;43269</td><td align="center" rowspan="1" colspan="1">Regulation of ion transport</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">1.90<italic>E</italic> &#x02212; 06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;9719</td><td align="center" rowspan="1" colspan="1">Response to endogenous stimulus</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">2.12<italic>E</italic> &#x02212; 06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;1903522</td><td align="center" rowspan="1" colspan="1">Regulation of blood circulation</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.21<italic>E</italic> &#x02212; 06</td></tr><tr><td align="left" rowspan="1" colspan="1">Cellular component</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;5615</td><td align="center" rowspan="1" colspan="1">Extracellular space</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">4.55<italic>E</italic> &#x02212; 10</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;44459</td><td align="center" rowspan="1" colspan="1">Plasma membrane part</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">1.61<italic>E</italic> &#x02212; 09</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;44421</td><td align="center" rowspan="1" colspan="1">Extracellular region part</td><td align="center" rowspan="1" colspan="1">58</td><td align="center" rowspan="1" colspan="1">6.19<italic>E</italic> &#x02212; 09</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;5576</td><td align="center" rowspan="1" colspan="1">Extracellular region</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">6.60<italic>E</italic> &#x02212; 09</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;31226</td><td align="center" rowspan="1" colspan="1">Intrinsic component of plasma membrane</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">7.45<italic>E</italic> &#x02212; 09</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;5887</td><td align="center" rowspan="1" colspan="1">Integral component of plasma membrane</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">4.49<italic>E</italic> &#x02212; 08</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;31224</td><td align="center" rowspan="1" colspan="1">Intrinsic component of membrane</td><td align="center" rowspan="1" colspan="1">72</td><td align="center" rowspan="1" colspan="1">4.86<italic>E</italic> &#x02212; 08</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;44425</td><td align="center" rowspan="1" colspan="1">Membrane part</td><td align="center" rowspan="1" colspan="1">85</td><td align="center" rowspan="1" colspan="1">7.79<italic>E</italic> &#x02212; 08</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;1990351</td><td align="center" rowspan="1" colspan="1">Transporter complex</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">3.66<italic>E</italic> &#x02212; 07</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;1902495</td><td align="center" rowspan="1" colspan="1">Transmembrane transporter complex</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">4.00<italic>E</italic> &#x02212; 07</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;16021</td><td align="center" rowspan="1" colspan="1">Integral component of membrane</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">4.13<italic>E</italic> &#x02212; 07</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;97458</td><td align="center" rowspan="1" colspan="1">Neuron part</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">4.20<italic>E</italic> &#x02212; 07</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;34702</td><td align="center" rowspan="1" colspan="1">Ion channel complex</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">2.16<italic>E</italic> &#x02212; 06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;5886</td><td align="center" rowspan="1" colspan="1">Plasma membrane</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">2.64<italic>E</italic> &#x02212; 06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;98590</td><td align="center" rowspan="1" colspan="1">Plasma membrane region</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">3.34<italic>E</italic> &#x02212; 05</td></tr><tr><td align="left" rowspan="1" colspan="1">Molecular function</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;0005201</td><td align="center" rowspan="1" colspan="1">Extracellular matrix structural constituent</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">2.82<italic>E</italic> &#x02212; 04</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;0043168</td><td align="center" rowspan="1" colspan="1">Anion binding</td><td align="center" rowspan="1" colspan="1">164</td><td align="center" rowspan="1" colspan="1">4.39<italic>E</italic> &#x02212; 04</td></tr></tbody></table></table-wrap><table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Top 15 enriched KEGG pathways of DEGs between gastric cancer and normal tissues.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">KEGG ID</th><th align="center" rowspan="1" colspan="1">KEGG term</th><th align="center" rowspan="1" colspan="1">Count</th><th align="center" rowspan="1" colspan="1">FDR</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">3040</td><td align="center" rowspan="1" colspan="1">Spliceosome</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">5.45<italic>E</italic> &#x02212; 34</td></tr><tr><td align="left" rowspan="1" colspan="1">4110</td><td align="center" rowspan="1" colspan="1">Cell cycle</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">4.81<italic>E</italic> &#x02212; 33</td></tr><tr><td align="left" rowspan="1" colspan="1">3013</td><td align="center" rowspan="1" colspan="1">RNA transport</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">8.58<italic>E</italic> &#x02212; 23</td></tr><tr><td align="left" rowspan="1" colspan="1">3008</td><td align="center" rowspan="1" colspan="1">Ribosome biogenesis in eukaryotes</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">5.29<italic>E</italic> &#x02212; 22</td></tr><tr><td align="left" rowspan="1" colspan="1">3030</td><td align="center" rowspan="1" colspan="1">DNA replication</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">8.72<italic>E</italic> &#x02212; 18</td></tr><tr><td align="left" rowspan="1" colspan="1">240</td><td align="center" rowspan="1" colspan="1">Pyrimidine metabolism</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">5.19<italic>E</italic> &#x02212; 14</td></tr><tr><td align="left" rowspan="1" colspan="1">230</td><td align="center" rowspan="1" colspan="1">Purine metabolism</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">1.11<italic>E</italic> &#x02212; 12</td></tr><tr><td align="left" rowspan="1" colspan="1">3430</td><td align="center" rowspan="1" colspan="1">Mismatch repair</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">5.98<italic>E</italic> &#x02212; 09</td></tr><tr><td align="left" rowspan="1" colspan="1">4114</td><td align="center" rowspan="1" colspan="1">Oocyte meiosis</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">2.78<italic>E</italic> &#x02212; 08</td></tr><tr><td align="left" rowspan="1" colspan="1">3440</td><td align="center" rowspan="1" colspan="1">Homologous recombination</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">3.89<italic>E</italic> &#x02212; 08</td></tr><tr><td align="left" rowspan="1" colspan="1">4914</td><td align="center" rowspan="1" colspan="1">Progesterone-mediated oocyte maturation</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">6.62<italic>E</italic> &#x02212; 08</td></tr><tr><td align="left" rowspan="1" colspan="1">3015</td><td align="center" rowspan="1" colspan="1">mRNA surveillance pathway</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">6.82<italic>E</italic> &#x02212; 08</td></tr><tr><td align="left" rowspan="1" colspan="1">4115</td><td align="center" rowspan="1" colspan="1">p53 signaling pathway</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">7.97<italic>E</italic> &#x02212; 08</td></tr><tr><td align="left" rowspan="1" colspan="1">4141</td><td align="center" rowspan="1" colspan="1">Protein processing in endoplasmic reticulum</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">1.10<italic>E</italic> &#x02212; 07</td></tr><tr><td align="left" rowspan="1" colspan="1">3018</td><td align="center" rowspan="1" colspan="1">RNA degradation</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">3.27<italic>E</italic> &#x02212; 07</td></tr></tbody></table></table-wrap><table-wrap id="tab5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Top ten TFs interacting with the most DEGs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">TFs</th><th align="center" rowspan="1" colspan="1">Log FC</th><th align="center" rowspan="1" colspan="1">Count</th><th align="left" rowspan="1" colspan="1">Genes</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BRCA1</td><td align="center" rowspan="1" colspan="1">1.067827</td><td align="center" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">SLC6A6, NHLRC3, TAF2, POGK, GMFB, NUSAP1, TCF20, CXCL1, FANCB, GCNT4, MPHOSPH9, TAF15, SMG1, WRAP53, HNRNPA2B1, AP1S3, ATP13A3, COPA, TMEM132A, PGM2L1, CTR9, DHX37, SAPCD2, INTS1, SLC30A7, THUMPD2, ZNF707, CCDC34, HMGN1, SLC35A2, ENPP6, CHUK, PRKCSH, ARMC10, RANBP1, LOC389906, CEP72, TIPIN, ILF3, GEMIN5, DCLRE1C, SPAG5, TRMT6, TTYH3, ZC3H11A, MIS18A, SUPV3L1, MND1, PTGES3</td></tr><tr><td align="center" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">ARID3A</td><td align="center" rowspan="1" colspan="1">0.844259</td><td align="center" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">MCM4, LSG1, NUP35, SPINT2, C18orf54, TASP1, REXO4, VCPIP1, AGTRAP, RFWD2, QTRTD1, PPP1R9B, CACNA2D3, ZNF207, AASDHPPT, CDC123, SLC6A4, STAMBPL1, HLF, GINS1, PIGU, TRIM37, CORO7-PAM16, ADRB2, CCNF, DDX31, TTLL5, CDH24, CAD, RPAP3, IWS1, ELK1, FBXO45, NEFL, PPP3R1, TARDBP, G2E3, AMPD1, SUPT7L, NMT1, TSLP, ORC1, FANCF, FAM213B, NUP93, TACC3, CHERP</td></tr><tr><td align="center" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> EHF</td><td align="center" rowspan="1" colspan="1">1.300121</td><td align="center" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">C9orf114, LRFN4, FTSJ3, LARP4, NFYA, PDRG1, ATP2A2, DPP6, ATP2C1, SNORD116-2, DCLRE1B, NME1-NME2, CENPL, ZNF146, STIL, NLK, MFAP2, DPAGT1, SNRNP200, GDF15, ATF6, UHMK1, IFI30, TRMT1, MLH3, PLBD2, PARG, ITGA2, DARS2, LY6E, KIF4A, ADPGK, USP2, TRUB1, FGFR4, BRMS1, NEIL3, ZNF598, SAFB, NCAPG2, C2orf15, MTHFD1</td></tr><tr><td align="center" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">SOX10</td><td align="center" rowspan="1" colspan="1">&#x02212;1.06478</td><td align="center" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">YWHAB, GCA, DTYMK, TAF4, STMN1, TOP1MT, RBM12B, RAD51D, DDX10, KIFC1, CCNE2, LOC100129034, SPTAN1, DNAJC14, NUP155, SUV39H2, SNX5, SST, AJUBA, ZBTB33, CCNB1, QSOX2, NVL, NOM1, OSBPL3, ILF3, UBE2T, UBE2C, SNRPF, CBX8, PKP4, EIF3J, GCN1L1, BAZ1A, EXO1, ESRRG, ANKRD52, AGFG1, SNRNP40, TBL1XR1, SPICE1, SGOL2</td></tr><tr><td align="center" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">ZNF263</td><td align="center" rowspan="1" colspan="1">0.435575</td><td align="center" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">PTGES3, R3HDM1, TTYH3, RPGRIP1L, POM121, KIF2C, GABPB1, SLC7A6, ZNF526, SYMPK, KLHL12, SETDB1, PAK2, HNRNPC, POLD3, TPR, NOM1, THBS2, SULF1, SYNJ2, ATP13A2, KIF20B, CHEK1, STIP1, LRPPRC, ZMYND15, LRRC3B, MAMDC2, TNFRSF10B, SOX4, AURKAPS1, NT5C1A, TMEM199, CDK5RAP1, RAI14, SHQ1, DSCC1, ATP2A2, PTGR1, ZSCAN29, PMM2</td></tr><tr><td align="center" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">FOXL1</td><td align="center" rowspan="1" colspan="1">0.691973</td><td align="center" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">BCCIP, CNOT6, CCT3, CKAP2L, ZNF335, XPO5, SMARCC1, BTG2, OLFM3, PSMD12, EFCAB11, WDYHV1, PALB2, NCAPD2, TMEM5, PDRG1, FHL1, SRP72, SORCS1, TEX261, TXNDC12, ATG7, DPAGT1, HIATL1, LAMB1, UBE2O, TCOF1, NIT2, PLEKHG4, TNRC18, DUS4L, NLRC5, STAU1, TP53BP1, POLG, SSB, MMS22L, RAI14</td></tr><tr><td align="center" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1"> FEV</td><td align="center" rowspan="1" colspan="1">&#x02212;0.75328</td><td align="center" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">WBP11, SH3KBP1, USP1, TIMM8A, KRT18, LTV1, ZNF485, PAK2, PODXL, ADHFE1, DIP2B, POLG2, PUS7, RCC2, DPM2, RPGRIP1L, BLOC1S2, WDR12, NCEH1, IWS1, COG2, DEPDC1, NCAM1, EPHB4, POLQ, CCT6A, MAPRE1, CENPW, SLC28A1, PIK3CB, RNF2, NSUN2, TYK2, DAZAP1, C2orf15, HN1L, SMYD5</td></tr><tr><td align="center" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">GATA3</td><td align="center" rowspan="1" colspan="1">0.606954</td><td align="center" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">FCHO1, ZDHHC9, CCNF, PIK3CB, TOP3A, ZNF678, EML4, WDR43, FANCM, GPN1, COL4A1, MB21D1, GORASP2, DUSP12, LGALS8, WDR3, CDC6, ZBTB41, EAF1, UFM1, HSPBAP1, PATL1, COL1A1, ARFGAP1, IKBIP, NOMO1, KAT2B, TTI1, SPG21, FAM107A, RAD51, HMMR, UHMK1, BMP1, ZC3H3</td></tr><tr><td align="center" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">FOXC1</td><td align="center" rowspan="1" colspan="1">1.210691</td><td align="center" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">VIT, PBK, AKAP8, ANAPC5, ILF2, NLN, RBM27, STX6, ZNF473, CHD4, MSH6, CREBZF, ZNF341, DBF4, ZNF107, PKP4, HNRNPD, CNOT6, U2SURP, CENPP, SFRP1, SUPV3L1, SFMBT1, CDKN3, NUP188, GCN1L1, NUPL1, MAMDC2, PMS1, RCCD1, UBQLN4, SMARCA5</td></tr><tr><td align="center" colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">FOXD1</td><td align="center" rowspan="1" colspan="1">0.795645</td><td align="center" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">MTPAP, BAZ1A, CHEK1, SLC30A5, NCL, MAPRE1, AQP4, USP14, EARS2, SYNCRIP, PALB2, SLC37A3, PHF6, POLR3E, TPM3, HOXB9, CD46, CLCN5, GOLT1B, C2orf44, AAGAB, NEK2, FAM208B, MYH9, UGGT1, NOL10, PRIMA1, ZNF92</td></tr></tbody></table></table-wrap></floats-group></article>